AAAAI Foundation
Funding research that leads to the prevention and cure of asthma and allergic and immunologic disease
Ways to Support

Ways to Support

The Isil Berat Barlan Memorial Lectureship

Professor Dr. Işıl Berat Barlan (1958-2015) was born in Trabzon, Turkey. She attended Robert College in Istanbul and received her medical degree from Istanbul University CerrahpaÅŸa Faculty of Medicine. She completed her residency in Pediatrics at Marmara University Faculty of Medicine, Istanbul. She trained in Allergy and Immunology first with Dr. Müjdat BaÅŸaran at Marmara University and later with Dr. Raif Geha at the Boston Children’s Hospital. She went on to become the Chair of Pediatrics and the Chief of the Division of Pediatric Allergy and Immunology at Marmara University.

Professor Barlan was a visionary physician-scientist who made a profound impact on the science and health care delivery in Allergy and Immunology in Turkey and beyond. She was a highly productive investigator, with more than 120 peer-reviewed papers in international and national Journals. Critically, she engaged in building a research and academic infrastructure in Allergy and Immunology in Turkey, established enduring international collaborations and mentored a large number of investigators and practitioners in the field. Professor Barlan has made numerous key contributions to the field of Allergy and Immunology at large. In a series of highly cited papers, she established the efficacy of pharmacotherapy with intranasal steroids in allergic rhinitis and rhinosinusitis, and that of sublingual immunotherapy for allergic upper airway disease and asthma. She also pioneered combination subcutaneous and sublingual immunotherapy for allergic asthma.

Professor Barlan made critical contributions in the field of primary immunodeficiencies (PID). Professor Barlan actively engaged in national and international collaborations on the investigation, diagnosis and management of primary immunodeficiency diseases.

She played a critical role in studies that led to the identification of DOCK8 deficiency as the underlying cause of the autosomal recessive form of the hyper IgE syndrome as well as other novel immunodeficiencies.

The ambitious scope of Professor Barlan’s studies was enabled by her creation of productive research and training programs and community outreach efforts. She established the first Jeffrey Modell Center for Primary Immunodeficiency and the first International Patient Organization for Primary Immunodeficiencies chapter in Turkey, both placed at Marmara University.

A critical achievement of Dr. Barlan was her training of a large number of academic physician-scientists in Allergy/Immunology, with many of her trainees assuming leadership positions in Turkey and abroad. Professor Barlan had a particular interest in women advancement in science, an issue that she strongly advocated for in both national and international forums. She trained several women physician-scientists, who went on to lead their own programs in Allergy and Immunology. Professor Barlan was a member of the AAAAI, and an active participant and speaker at its annual meetings. She served on the executive committee of the European Academy of Allergy and Clinical Immunology (EAACI). She was the recipient of a number of awards, including the highly prestigious Sedat Simavi Prize in Turkey for her scientific contributions in the field of immunotherapy, as well as multiple prizes by the Turkish Society of Pediatrics, Marmara University Medical Faculty and Istanbul  Provincial Directorate for her medical research and clinical excellence.

If you wish to honor Dr. Barlan, please consider a gift to the AAAAI Foundation. A donation in any amount can be dedicated to this effort. Your donation makes a difference. We appreciate your support and your commitment to our specialty. For questions or to make a contribution by phone, call the AAAAI Foundation Office at (414) 272-6071

Cookie Notice

This site uses cookies. By continuing to browse this site, you are agreeing to our use of cookies. Review our cookies information for more details.